Patent · US Expired

Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA

US7910563B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Antisense Pharma GmbH · DE

Inventors

Karl-Hermann Schlingensiepen · Bovenden, DE
Reimar Schlingensiepen · Regensburg, DE

Key dates

Filing date	Aug 11, 2004
Grant date	Mar 22, 2011
Priority date	—
Expiry date	Aug 11, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/3515
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antisense oligonucleotide selected from the group of

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.